home / stock / ktta / ktta news


KTTA News and Press, Pasithea Therapeutics Corp. From 02/12/24

Stock Information

Company Name: Pasithea Therapeutics Corp.
Stock Symbol: KTTA
Market: NASDAQ
Website: pasithea.com

Menu

KTTA KTTA Quote KTTA Short KTTA News KTTA Articles KTTA Message Board
Get KTTA Alerts

News, Short Squeeze, Breakout and More Instantly...

KTTA - Expected US Company Earnings on Monday, February 12th, 2024

Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023 Pioneer Bancorp Inc. (PBFS) is expected to report for Q2 2024 Equity Commonwealth of Beneficial Interest (EQC) is expected to report $0.27 for Q4 2023 monday.com Ltd. (MNDY) is expected to report $-0.31 for Q4 2023 As...

KTTA - Expected earnings - Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. (KTTA) is expected to report for Q4 2023

KTTA - (KTTA) Trading Report

2024-02-05 01:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KTTA - How to Take Advantage of moves in (KTTA)

2024-01-25 10:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KTTA - Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position

-- Polymorph and Stereoisomer Patents when Issued Extend Portfolio to at least 2045 -- -- Polymorph and Stereoisomer Patent Filings Continue to Expand Patent Portfolio -- SOUTH SAN FRANCISCO, Calif. and MIAMI, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. ...

KTTA - Pasithea conducts 1-for-20 reverse stock split, gets FDA okay for study

2024-01-02 09:11:26 ET More on Pasithea Therapeutics Pasithea stock soars as high as 190% on preclinical data Pasithea stock jumps 12% on update for anti-tumor drug PAS-004 Financial information for Pasithea Therapeutics For further details see: Pasithea ...

KTTA - Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

-- PAS-004 is the first macrocyclic MEK inhibitor to enter human clinical trials -- -- Phase 1 dose escalation study in patients with MAPK pathway driven advanced solid tumors to begin in Q1 2024 – -- Initial readout expected as early as Q3 2024 – SOUTH SAN FRANCISCO, ...

KTTA - Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA) today announced that its meeting of stockholders, which had been partially adjourned on December 19, 2023, was reconvened o...

KTTA - Pasithea Therapeutics Announces Results from 2023 Annual Meeting

SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA), today announced that it held its annual meeting of stockholders (the “Annual Meeting”) on December 19, 2023....

KTTA - RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With 'Overweight' Rating

2023-12-13 10:22:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Roblox (NYSE: RBLX ) stock is on the move Wednesday as investors react to new coverage of the video game company’s shares from Wells Fargo. Wells Fargo analysts initiat...

Previous 10 Next 10